Guardant Health, a Palo Alto-based company, gained approval from the Food and Drug Administration on a first-of-its-kind blood test to be used for colorectal cancer screenings this month, which is now commercially available.
The post Peninsula company gets key FDA approval for cancer blood screening appeared first on The Almanac.